GeneDx Holdings Corp. (WGS)
NASDAQ: WGS · Real-Time Price · USD
92.20
-2.14 (-2.27%)
At close: Mar 28, 2025, 4:00 PM
92.32
+0.12 (0.13%)
After-hours: Mar 28, 2025, 7:19 PM EDT
GeneDx Holdings Market Cap
GeneDx Holdings has a market cap or net worth of $2.59 billion as of March 28, 2025. Its market cap has increased by 828.32% in one year.
Market Cap
2.59B
Enterprise Value
2.56B
1-Year Change
828.32%
Ranking
Category
Stock Price
$92.20
Market Cap Chart
Since November 4, 2020, GeneDx Holdings's market cap has decreased from $17.90B to $2.59B, a decrease of -85.54%. That is a compound annual growth rate of -35.58%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 28, 2025 | 2.59B | 22.56% |
| Dec 31, 2024 | 2.11B | 2,866.28% |
| Dec 29, 2023 | 71.18M | -30.24% |
| Dec 30, 2022 | 102.04M | -90.52% |
| Dec 31, 2021 | 1.08B | -94.66% |
| Dec 31, 2020 | 20.16B | 12.65% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 738.61B |
| UnitedHealth Group | 472.03B |
| Johnson & Johnson | 394.52B |
| AbbVie | 363.15B |
| Novo Nordisk | 305.46B |
| AstraZeneca | 229.16B |
| Abbott Laboratories | 226.88B |
| Merck & Co. | 225.40B |